comparemela.com

Latest Breaking News On - Biocon biologics limited - Page 1 : comparemela.com

Eris Lifesciences Q4 results: Net profit up 29 5% to Rs 79 6 crore

Eris Lifesciences Q4: Revenue came in at Rs 550.9 crore, up 36 percent from the year-ago quarter

Swiss parenteralsBiocon biologicsEris lifesciences ltdNational stock exchangeLifesciences ltdEris lifesciencesSwiss parenterals limitedIndian branded formulationsCritical careBiocon biologics limited

Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges

Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesAndhra pradeshDoretta mistrasBiocon biologicsScotta smithBiocon biologics limitedViatris incCompany annual report on formTotal revenuesCash providedOperating activitiesFree cash flowFourth consecutive quarterOperational revenue growthProduct revenue rangeIdorsia transaction

Biocon shares in focus today as US FDA issues four observations for insulin facility

Biocon stock ended 2.05% higher at Rs 276.50 on Thursday against the previous close of Rs 270.95 on BSE. The stock touched an intraday high of Rs 277.60 .

United statesBiocon biologicsDrug administrationBiocon biologics limited campus siteBiocon ltdUnited states foodBiocon biologics limitedBiocon campusDrug substancePre approval supplementPreventive action

US FDA issues 4 observations for Biocon Biologics insulin facility

The trigger for this inspection was a Pre-Approval Supplement (PAS) filed by BBL s customer late last year

United statesBiocon biologicsBiocon biologics limited campus siteDrug administrationUnited states foodBiocon biologics limitedBiocon campusDrug substancePre approval supplementPreventive actionBiocon biologics

Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®

Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth australiaBiocon biologicsShreehas tambeMatthew erickUn sustainable development goals sdgs websiteBiocon ltdTrademarks officeJanssen biotech incBiocon biologics ltdCompany biologics license applicationBiologics ltdBiologics license applicationInter partes reviewPatent trialAppeal board

vimarsana © 2020. All Rights Reserved.